Turnstone Biologics Corp.
TSBX
$0.35
$0.0319.72%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.87M | -17.03M | -21.30M | -19.63M | -16.45M |
| Total Depreciation and Amortization | 337.00K | 491.00K | 498.00K | 509.00K | 659.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 352.00K | 377.00K | 500.00K | 288.00K | 76.00K |
| Change in Net Operating Assets | -4.29M | -1.41M | 4.38M | 1.37M | 211.00K |
| Cash from Operations | -16.48M | -17.58M | -15.93M | -17.46M | -15.50M |
| Capital Expenditure | 19.00K | 1.00K | -105.00K | -144.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 25.00K | -- | 272.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.25M | 24.25M | 19.02M | 14.24M | -5.58M |
| Cash from Investing | 21.27M | 24.25M | 18.94M | 14.10M | -5.31M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 44.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -169.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 59.00K | -92.00K | -- | 0.00 |
| Cash from Financing | 0.00 | 59.00K | -48.00K | -- | -169.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.79M | 6.73M | 2.97M | -3.37M | -20.98M |